AGTC Licenses Promoter Technology to SparingVision SAS
UF startup and UF Innovate | Sid Martin Biotech alum Applied Genetic Technologies Corporation (AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, announced a licensing agreement that provides its proprietary cone-specific promoter technology to SparingVision SAS, a genomic medicine company developing vision-saving treatments for ocular diseases.
SATLANTIS Receives Investment From Two Spanish Companies
UF startup and UF Innovate | The Hub resident client SATLANTIS, a company specializing in high-performance optical loads for observation of the Earth for small satellites, has had the entry into its shareholding by Enagás, the main natural gas transporter in Spain, after a capital increase of 14 million euros.
New Grant Will Help Develop Vaccine Delivery System for Tilapia Lake Virus
The Foundation for Food and Agriculture Research (FFAR) has joined in the war against the tilapia lake virus (TLV) with a US$ 790,326 (EUR 671,206) Seeding Solutions grant award to the University of Florida in support of the development of a vaccine delivery system for halting the spread of the disease.
Artificial Intelligence Leads the Way in a Sea Change for Agriculture
UF agricultural engineer Yiannis Ampatzidis says artificial intelligence — the convergence of new tools for data collection with cloud computing to analyze the explosion of information — is changing the face of agriculture in a way that is nothing short of revolutionary.
Tampa Bay Company Searching for Other Vaccine Methods
UF startup and UF Innovate | Sid Martin Biotech graduate Oragenics, Inc., a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis, is in the pre-clinical phase of developing a vaccine they say would solve two critical problems when it comes to ending the pandemic.
Stuart Raetzman Appointed as Interim CEO at TearClear
UF startup and UF Innovate | Sid Martin Biotech resident client TearClear has appointed Stuart Raetzman as interim CEO and is preparing for a pivotal study on proprietary latanoprost for glaucoma treatment, according to a press release.
TearClear Moving Toward Clinical Trials and Strengthening Leadership Team
UF startup and UF Innovate | Sid Martin Biotech resident client TearClear, an emerging ophthalmic pharmaceutical company, continues to make progress on the development of its first-in-class platform of preservative-free topical medications.
Evolugate Improves DNA-Plasmid Production, Ready To Impact COVID-19 Vaccines Manufacturing Throughput
UF startup Evolugate, LLC, a Gainesville-based biotech company, has demonstrated that its proprietary technology can be used to improve the throughput of plasmid DNA manufacturing.
Everything You Need To Know About Vaccines and COVID-19
Dr. Peter Khoury, president and CEO of UF startup and UF Innovate | Sid Martin Biotech graduate Ology Bioservices, Inc., a biologics contract development and manufacturing organization (CDMO), talked with James Di Virgilio, Radio Cade's host, about vaccinations and COVID-19.
Oragenics Chases Vaccine for Niche Markets
UF startup and UF Innovate | Sid Martin Biotech graduate Oragenics, a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis, seeks to be a major player in the Super Bowl of the pharmaceutical industry: a COVID-19 vaccine.
